MEMPHASYS LIMITED. — Regulatory Filings 2012

Nov 14, 2012

==> picture [197 x 25] intentionally omitted <==

==> picture [197 x 25] intentionally omitted <==

==> picture [197 x 25] intentionally omitted <==

==> picture [197 x 24] intentionally omitted <==

FOR IMMEDIATE RELEASE

Prof John Aitken, developer of NuSep’s SpermSep, Awarded as NSW Scientist of the Year 2012

Sydney, Australia 15[th ] November 2012 - NuSep (ASX: NSP) congratulates Laureate Professor John Aitken for being named NSW Scientist of the Year at the 2012 NSW Science and Engineering awards. Professor Aitken is the Chairman of NuSep’s Scientific Advisory Committee.

The prestigious NSW Scientist of the Year prize is awarded to an outstanding individual who has made a significant contribution to the advancement of science and/or engineering that benefits or has the potential to benefit our community.

The award, announced in Sydney on Wednesday 14[th] November 2012 by Minister for Regional Infrastructure and Services Andrew Stoner, recognised Professor Aitken’s world-class work in reproductive biology.

The NSW Science and Engineering Awards were initiated in 2008 to recognise and reward the State's leading researchers in science and engineering for cutting edge work that generates economic, health, environmental or technological benefits for NSW.

Professor Aitken has identified oxidative stress as a major cause of male infertility, a finding that has resulted in new methods of therapeutic intervention, including sperm isolation using NuSep’s Sperm Separation device, the SpermSep. He has directed distinguished research on mammalian sperm function, fertilisation and early embryonic development with applications in fertility treatments. His team has also developed potential contraceptive agents that could prevent pregnancy and simultaneously inhibit the spread of sexually transmitted diseases.

Dr Hari Nair, Group Managing Director of NuSep said, “NuSep congratulates Professor Aitken on receiving this award and is proud to be associated with his work. John is a very important contributor to NuSep’s endeavour to commercialise the SpermSep and we look forward to working with him in the future.”

ENDS

For more information please contact:

Contact: Swapna Keskar Company Secretary +61 2 8415 7300 keskar@companymatters.com.au

Contact Details Telephone +61 2 8415 7300 Facsimile +61 2 8415 7399

Email info@nusep.com Web www.nusep.com ABN 33 120 047 556

NuSep Holdings Ltd 324 Burns Bay Rd Lane Cove NSW 2066

Postal Address P.O. Box 823 Lane Cove NSW 1595

– 2 –

About NuSep

NuSep (ASX: NSP) is a publicly listed life sciences company that sells products into the global BioSeparations market. NuSep recently acquired BioInquire which developed the ProteoIQ software enabling NuSep to offer a total Proteomics solution from Fraction to Function . The company has offices in both Sydney Australia and Atlanta, USA.

With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques including the world’s first IVF sperm separation device. In short NuSep has redefined the BioSeparations market through innovation and simplification.

NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia.

NuSep Products:

==> picture [12 x 17] intentionally omitted <==

• Gels – NuSep manufactures and sells precast gels including the innovative nUView Gels, which can be visualised 2 minutes after use.

==> picture [12 x 17] intentionally omitted <==

• Separation Instruments – NuSep has developed two unique biological separation instruments. The ProteomeSep was released in 2009 and can separate biological samples into 8 fractions for use in the proteomic market. The SpermSep separates sperm for fertility treatments such as IVF.

==> picture [12 x 17] intentionally omitted <==

• Proteomics Software – NuSep offers the unique ProteoIQ software for the analysis of complex mass spec samples. This software is also designed to identify bio markers.

==> picture [12 x 17] intentionally omitted <==

• Biological Products – NuSep supplies research grade biological products manufactured using its unique separation technologies. These products include human IgG and Albumin .

For more information about NuSep please visit the company’s website www.NuSep.com

About PrIME Biologics Pte Ltd

PrIME Biologics is a Singapore based biotech company that has developed a disposable therapeutic plasma manufacturing process based on NuSep’s PrIME Technology. NuSep has a 90% shareholding in PrIME Biologics. PrIME Biologics process is based on the Pr eparative I solation by M embrane E lectrophoresis (PrIME) technology developed by NuSep. PrIME provides disposable modular processing that is ‘electronically’ driven membrane fractionation.

The PrIME process increases product yields to over 90% relative to the existing process 50% while increasing product safety. The PrIME has been shown to remove virus, bacteria, endotoxins and prions which cause ‘Mad Cow Disease’. Further, PrIME Biologics process can produce multiple plasma products in hours compared to days, which is required by the current manufacturers.

The initial application for the PrIME process will be the Currently Unprocessable Plasma which represents approximately 50% of all the plasma collected in many Asian countries.